From climate and public lands to shifting political allegiances, the region faces critical choices at the ballot box.

PRAIRIE DU CHIEN – Former President Donald Trump returned to western Wisconsin Saturday to give remarks in Prairie du Chien, a city of about 5,500 people along the Mississippi River that has ...

PRAIRIE DU CHIEN – Former President Donald Trump returned to western Wisconsin Saturday to give remarks in Prairie du Chien, a city of about 5,500 people along the Mississippi River that has gotten ...

Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. These players, as well as ...

Donanemab, manufactured by Eli Lilly (LLY), is the latest in a new class of anti-amyloid drugs that deliver antibodies to target beta-amyloid, a protein linked to Alzheimer's disease. Initially ...

That race, which pits incumbent Rep. Ryan Zinke, a Republican and former Interior Secretary, against Democratic challenger Monica Tranel, is a very close contest according to a poll released on ...

The most recent trading session ended with Eli Lilly (LLY) standing at $909.32, reflecting a -1.65% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.4%.

That race, which pits incumbent Rep. Ryan Zinke, a Republican and former Interior Secretary, against Democratic challenger Monica Tranel, is a very close contest according to a poll released on ...

Western Congressional District candidate Monica Tranel, a Democrat, walks in the Labor Day Parade in Dillon, Montana (Photo courtesy of Monica Tranel campaign). Even though the U.S. Senate race ...

I can only imagine how much worse it’ll be if we elect a radical environmental liberal like Monica Tranel. She claims she’ll make Montana more affordable, but her record suggests otherwise.

Sept 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment ...